Cocrystals of Fenamic Acids with Nicotinamide
Source abstract
Abstract
Cocrystal formation between nicotinamide and five fenamic acid derivative drugs (flufenamic acid, niflumic acid, tolfenamic acid, mefenamic acid and meclofenamic acid) was investigated using solution-based and solid-state preparation methods. It was anticipated that the well-known acid–aromatic nitrogen heterosynthon would provide a sufficient driving force for cocrystallization. The experiments yielded cocrystals with four of the five acids. Although the structures of these molecules are similar, they showed marked differences in both the stability and the stoichiometry of the cocrystals. A detailed analysis of the structures and properties of both the starting materials and the cocrystals allows a tentative explanation of these differences, but it also shows that even though all four cocrystals utilize one of the most predictable supramolecular synthons (COOH···N), their structures and properties remain elusive to design.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Crystal structures of chemical compounds · Crystallization and Solubility Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Analytical and Biological Chemistry Research Facility, University College Cork, Cork, Ireland
Almac Sciences, Seagoe Industrial Estate, Craigavon, United Kingdom
Department of Chemistry and School of Pharmacy, Analytical and Biological Chemistry Research Facility, University College Cork, Cork, Ireland
References (52)
Show source-provided references
1. Khansari P. S. · Neurochem. Int. · 2009 · 55 · 68310.1016/j.neuint.2009.06.014 ↗
2. Lee S.-H. · Oncogene · 2010 · 29 · 518210.1038/onc.2010.251 ↗
3. Pedersen S. B. · Pharmacol. Toxicol. · 1994 · 75 · 2210.1111/j.1600-0773.1994.tb01992.x ↗
4. Glazko A. J. · Curr. Ther. Res. · 1978 · 23 · 22
5. Cafaggi S. · Eur. J. Pharm. Sci. · 2008 · 35 · 1910.1016/j.ejps.2008.05.010 ↗
6. Vavia P. R. · Pharm. Dev. Technol. · 2000 · 5 · 57110.1081/PDT-100102040 ↗
7. Del Arco M. · Clay Miner. · 2008 · 43 · 25510.1180/claymin.2008.043.2.08 ↗
8. Pandey M. · J. Pharm. Res. · 2010 · 3 · 146
9. Fang L. · J. Pharm. Sci. · 2004 · 93 · 14410.1002/jps.10468 ↗
10. Fonari M. S. · Cryst. Growth Des. · 2010 · 10 · 364710.1021/cg100518b ↗
11. Thybo P. · Pharm. Dev. Technol. · 2007 · 12 · 4310.1080/10837450601166577 ↗
12. McNamara D. P. · Pharm. Res. · 2006 · 23 · 188810.1007/s11095-006-9032-3 ↗
13. Báthori N. B · Cryst. Growth Des. · 2011 · 7510.1021/cg100670k ↗
14. Eccles K. S. · J. Org. Chem. · 2011 · 76 · 115910.1021/jo102148p ↗
15. Lemmerer A. · Acta Crystallogr., Sect. B · 2008 · 64 · 78010.1107/S0108768108034526 ↗
16. Aakeröy C. B · J. Am. Chem. Soc. · 2002 · 124 · 1442510.1021/ja027845q ↗
17. Karki S. · CrystEngComm · 2009 · 11 · 47010.1039/B812531G ↗
18. Lemmerer A. · J. Pharm. Sci. · 2010 · 99 · 405410.1002/jps.22211 ↗
19. Berry D. J. · Cryst. Growth Des. · 2008 · 8 · 169710.1021/cg800035w ↗
20. Chadwick K. · Cryst. Growth Des. · 2009 · 9 · 199010.1021/cg8013078 ↗
21. Trask A. V. · Top. Curr. Chem. · 2005 · 254 · 4110.1007/b100995 ↗
22. Aher S. · Eur. J. Pharm. Sci. · 2010 · 41 · 59710.1016/j.ejps.2010.08.012 ↗
23. 2009
24. Sheldrick G. M. · Acta Crystallogr., Sect. A · 2008 · 64 · 11210.1107/S0108767307043930 ↗
25. Macrae C. F. · J. Appl. Crystallogr. · 2008 · 41 · 46610.1107/S0021889807067908 ↗
26. Patterson B. D. · Nucl. Instrum. Methods Phys. Res., Sect. A · 2005 · 540 · 4210.1016/j.nima.2004.11.018 ↗
27. Bergamaschi A. · J. Synchrotron Radiat. · 2010 · 17 · 65310.1107/S0909049510026051 ↗
28. David W. I. F. · J. Appl. Crystallogr. · 2006 · 39 · 91010.1107/S0021889806042117 ↗
29. Toby B. H. · J. Appl. Crystallogr. · 2001 · 34 · 21010.1107/S0021889801002242 ↗
30. Larson A. C. · Los Alamos National Laboratory Report LAUR · 2004 · 86
31. Stephens P. · J. Appl. Crystallogr. · 1999 · 32 · 28110.1107/S0021889898006001 ↗
32. Li Z. · Org. Process Res. Dev. · 2009 · 13 · 130710.1021/op900137j ↗
33. Chiarella R. A. · Cryst. Growth Des. · 2007 · 7 · 122310.1021/cg070218y ↗
34. Surov A. O. · Cryst. Growth Des. · 2009 · 9 · 326510.1021/cg900002q ↗
35. Fawzi, M. B.; Mahjour, M.U.S. Patent 5373022.
36. Hino T. · Thermochim. Acta · 2001 · 374 · 8510.1016/S0040-6031(01)00491-9 ↗
37. Krishna M. H. M. · Acta Crystallogr., Sect. B · 1982 · 38 · 31510.1107/S0567740882002763 ↗
38. McConnell J. F. · Cryst. Struct. Commun. · 1973 · 2 · 459
39. Murthy H. M. K. · Acta Crystallogr., Sect. B · 1979 · 35 · 26210.1107/S0567740879003253 ↗
40. Andersen K. V. · J. Chem. Soc., Perkin Trans. 2 · 1989 · 58 · 144310.1039/p29890001443 ↗
41. López-Mejías V. · J. Am. Chem. Soc. · 2009 · 131 · 455410.1021/ja806289a ↗
42. McConnell J. F. · Cryst. Struct. Comm. · 1976 · 5 · 861
43. Lee E. H. · Pharm. Res. · 2006 · 23 · 237510.1007/s11095-006-9045-y ↗
44. Murthy H. M. K. · Acta Crystallogr., Sect. B · 1981 · 37 · 110210.1107/S0567740881005141 ↗
45. Llinàs A. · J. Chem. Inf. Model. · 2008 · 48 · 128910.1021/ci800058v ↗
46. Hopfinger A. J. · J. Chem. Inf. Model. · 2009 · 49 · 110.1021/ci800436c ↗
47. Pentikäinen P. J. · Eur. J. Drug Metab. Pharmacokinet. · 1982 · 7 · 25910.1007/BF03189628 ↗
48. Domanska U. · J. Chem. Thermodyn. · 2010 · 42 · 146510.1016/j.jct.2010.07.001 ↗
49. Domanska U. · J. Phys. Chem. B · 2009 · 113 · 894110.1021/jp900468w ↗
50. Miwa Y. · Acta Crystallogr., Sect. B · 1999 · 55 · 7810.1107/S0108768198007848 ↗
51. Li J. · Chem. Commun. · 2011 · 47 · 153010.1039/C0CC04117C ↗
52. Fábián L. · Acta Crystallogr., Sect. B · 1999 · 55 · 109910.1107/S0108768199009325 ↗